Design, synthesis and evaluation of structurally diverse polycyclic harmaline scaffolds as anticancer agents
Here, we demonstrate that the first example of harmaline scaffolds serving as acceptor/acceptor-based N-C-C synthons triggered the ring opening and skeletal reconstruction of 3-vinyl benzofuranones for the construction of a library of skeletally diverse polycyclic harmaline scaffolds. These products...
Saved in:
Published in | New journal of chemistry Vol. 48; no. 14; pp. 6322 - 6334 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
CAMBRIDGE
Royal Soc Chemistry
02.04.2024
Royal Society of Chemistry |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Here, we demonstrate that the first example of harmaline scaffolds serving as acceptor/acceptor-based N-C-C synthons triggered the ring opening and skeletal reconstruction of 3-vinyl benzofuranones for the construction of a library of skeletally diverse polycyclic harmaline scaffolds. These products were smoothly afforded in up to 77% yield, >20 : 1 dr under catalyst-free conditions, and expanded the chemical space of biologically significant harmaline derivative species. All synthetic compounds showed cytotoxic activity against tumor cells, especially compound
3at
, which exhibited selective cytotoxicity against A549 cells and lower cytotoxicity against normal cells MRC-5 and HK-2. In further mechanism research,
3at
inhibited A549 cell proliferation through the G1 phase arrest, induced A549 cell apoptosis through internal and external apoptosis pathways, and suppressed the migration and invasion abilities of A549 cells. These data indicated that compound
3at
is the most effective compound in the series and can serve as a promising precursor for drug development.
This is the first example of harmaline scaffolds as acceptor/acceptor-based N-C-C synthons and evaluation of
3at
as an anticancer agent. |
---|---|
Bibliography: | Electronic supplementary information (ESI) available. CCDC 2323856 ( https://doi.org/10.1039/d4nj00306c For ESI and crystallographic data in CIF or other electronic format see DOI 3aj |
ISSN: | 1144-0546 1369-9261 |
DOI: | 10.1039/d4nj00306c |